Intellia Therapeutics Inc (NASDAQ:NTLA) currently has a daily average trading volume of 3.54M but it saw 4183791 shares traded in last market. With a market cap of 952.97M USD, the company’s current market price of $9.20 came falling about -4.86 while comparing to the previous closing price of $9.67. In past 52 weeks, the stock remained buoying in the range of price level as high as $28.18 and as low as $5.90.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wolfe Research which upgraded the stock as “Outperform” in its note to investors issued on April 21, 2025, recommending a price target of $21 for it. JP Morgan issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $45 and $13.
Over the week, NTLA’s stock price is moving 16.75% up while it is 10.71% when we observe its performance for the past one month. Year-to-date it is -21.10% down and over the past year, the stock is showing a downside performance of -64.91%.
Currently, Intellia Therapeutics Inc’s total number of outstanding shares is 103.54M with 4.96% of that held by the insiders while 96.90% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -61.12% and return on equity (ROE) at -57.92%. Stock’s beta reads 2.26. Stock has a price to book (P/B) ratio of 1.22 while price to sale or P/S ratio amounts to 20.91. Its return on asset (ROA) is -46.84% on average.
